Propionate is a SCFA that can be produced by gut bacteria through the fermentation of key fibers or the metabolism of lactate. Propionate supports a healthy immune system by encouraging regulatory T cell differentiation in gut associated lymphoid tissues (GALT), and it also promotes gluconeogenesis in the liver, supports insulin sensitivity, and improves gut hormone production. Propionate and butyrate both work together to support healthy inflammatory responses by inhibiting histone deacetylases (HDACs) in macrophages and dendritic cells.

Propionibacterium freudenreichii, identified in a gut microbiome test, is a significant bacterium that offers intriguing insights into the health and balance of the gut ecosystem. This species is part of the Propionibacterium genus, known for its unique metabolic properties, particularly in the production of propionic acid – a beneficial short-chain fatty acid (SCFA) with several important roles in gut health. SCFAs, like propionic acid, are crucial for maintaining the health of the colon, regulating the immune system, and ensuring the integrity of the gut barrier. The presence of Propionibacterium freudenreichii in the gut is influenced by dietary habits, especially the consumption of specific types of fibers and dairy products, which can serve as substrates for its fermentation processes. A balanced diet rich in diverse fibers and fermented dairy products like cheese can support the growth and activity of this bacterium. The health of the overall gut microbiota also plays a role in regulating its levels. Propionibacterium freudenreichii is known for its probiotic properties and is often used in the fermentation of dairy products. In the gut, it contributes to the fermentation of dietary fibers, leading to the production of propionic acid. This SCFA has several health benefits, including anti-inflammatory effects, potential cancer-fighting properties, and the ability to regulate blood sugar levels. Moreover, it helps in maintaining a healthy gut environment by supporting the growth of other beneficial bacteria and inhibiting the growth of harmful pathogens. While the presence of Propionibacterium freudenreichii is generally considered beneficial, an imbalance in its levels, either too high or too low, can be indicative of broader gut microbiota imbalances. A lower abundance may lead to reduced SCFA production and potentially impact gut health negatively, while an overgrowth could be symptomatic of an underlying dysbiosis or specific dietary imbalances. To manage levels of Propionibacterium freudenreichii, dietary interventions are often the primary approach. This includes consuming a diet high in fiber from a variety of plant sources and fermented dairy products, which provide the necessary substrates for its growth. Probiotic supplements containing Propionibacterium freudenreichii can also be beneficial in maintaining or restoring a balanced gut microbiota. In cases where imbalances in Propionibacterium freudenreichii are linked to specific gastrointestinal conditions, healthcare professionals may suggest additional diagnostic testing and targeted treatments. These might include personalized dietary plans or probiotic supplements tailored to individual gut microbiota profiles.

Propionylglycine is a N-acylglycine obtained by formal condensation of the carboxy group of propionic acid with the amino group of glycine. It has a role as a human urinary metabolite. It is functionally related to a propionic acid. It is a conjugate acid of a propionylglycinate. Propionylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase. The level of propionylglycine is elevated in patients with propionic acidemia, which is an inherited deficiency of propionyl-CoA carboxylase. Propionic acidemia is a rare metabolic disorder. Symptoms most commonly become apparent during the first weeks of life and may include abnormally diminished muscle tone (hypotonia), poor feeding, vomiting, listlessness (lethargy), dehydration and seizures. Without appropriate treatment, coma and death may result. Rarely, the condition may become apparent later in life and may be associated with less severe symptoms and findings. Propionic acidemia is inherited in an autosomal recessive pattern. Individuals with this condition have to follow a specific diet including a low protein intake and specific food formulas (medical foods). Liver transplant is a surgical option that can help decrease the frequency of acute metabolic episodes (decompensation). References: National Center for Biotechnology Information. PubChem Compound Summary for CID 98681, N-Propionylglycine. https://pubchem.ncbi.nlm.nih.gov/compound/N-Propionylglycine. Accessed May 24, 2023. Links: https://rarediseases.org/rare-diseases/propionic-acidemia/#disease-overview-main

Total Prostate Specific Antigen (TPSA) is a serine protease produced by prostate cells, primarily used as a biomarker for the screening and monitoring of prostate cancer. While elevated TPSA levels can indicate the presence of prostate cancer, they can also arise from benign conditions such as benign prostatic hyperplasia (BPH) and prostatitis. The TPSA test measures the total amount of PSA in the blood, which includes both free and protein-bound forms. Although TPSA is a valuable tool in early detection and management of prostate cancer, its specificity is limited, as elevated levels can occur in non-cancerous conditions. Therefore, healthcare providers often use additional tests, such as the free-to-total PSA ratio, to improve diagnostic accuracy and differentiate between benign and malignant prostate conditions.

Part of Prostate

Prostate volume, the measure of the size of the prostate gland, is a significant factor in men's health, particularly in the context of conditions like benign prostatic hyperplasia (BPH) and prostate cancer. In healthy adult men, the average prostate volume is about 20-30 milliliters, roughly the size of a walnut. However, prostate size can vary and tends to increase with age. Enlargement of the prostate, often seen in BPH, can lead to symptoms like urinary frequency, urgency, and difficulty in urination. Prostate volume is typically assessed through medical imaging techniques like ultrasound or MRI and can play a role in diagnosing and managing prostate-related conditions.